UFP Technologies, Inc. (UFPT) Cash Flow Statement

The OCF/NI ratio of 0.75 in Q2 2026, though improved from the prior quarter's 0.18, remains below the 1.0 threshold, indicating that earnings are not yet fully converting to cash. The negative working capital change of -$15.6M in Q2 suggests that receivables or inventory absorbed cash, likely due to revenue acceleration. Investors should monitor whether this is a temporary timing issue or a persistent drag on cash generation.

The sequential FCF improvement is encouraging, yet the wide quarterly swings—from 0.9% to 21.1% over the past year—suggest that FCF is not yet a stable metric. This volatility likely stems from working capital swings rather than capex, as capital intensity remains low at under 3% of revenue. The company's FCF margin is still below the peer average, indicating room for operational improvement if working capital can be managed more consistently.

UFPT's capex/revenue ratio of 0.7% in Q2 2026 is minimal, suggesting that the company's growth does not require heavy fixed asset investment. This supports a high FCF conversion potential, but also implies that organic growth may be constrained by capacity. The low capex may indicate that the company relies on acquisitions for expansion, which could introduce integration risk.

The persistent negative working capital changes suggest that UFPT's growth is consuming cash, likely due to increasing receivables and inventory to support higher sales. The Q2 2026 swing of -$15.6M is particularly large, offsetting the positive net income. This pattern indicates that the company may need to improve its working capital efficiency to sustain cash generation, especially as revenue grows.

The company's capital deployment strategy is clearly focused on inorganic growth, with a significant acquisition in Q3 2024. The absence of shareholder returns suggests that management is prioritizing reinvestment, which aligns with the medical segment pivot. However, the lack of buybacks or dividends may disappoint income-focused investors, and the reliance on acquisitions introduces execution risk.

The cumulative OCF of $177.0M is actually higher than net income, but this is skewed by a few strong quarters. The more telling signal is the quarterly volatility, where OCF/NI ranges from 0.18 to 2.19. This suggests that earnings quality is not consistently high, and investors should focus on the underlying drivers of working capital changes to assess sustainability.